Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HK
1601
DELISTED
Halcon Resources Corporation
HK
| $2.6M | 0.01% |
+3,904
| New | +$3.03M |
|
1602
MillerKnoll
MLKN
$1.56B
| $2.58M | 0.01% |
87,365
-123,800
| -59% | -$3.7M |
|
|
ACH
1603
Accendra Health
ACH
$254M
| $2.58M | 0.01% |
+70,550
| New | +$2.59M |
|
|
HOME
1604
DELISTED
HOME FED BANCORP INC COM STK NEW (MD)
HOME
| $2.57M | 0.01% |
172,711
+26,200
| +18% | +$380K |
|
1605
STRATTEC Security
STRT
$376M
| $2.57M | 0.01% |
57,565
+10,200
| +22% | +$433K |
|
|
SDLP
1606
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $2.57M | 0.01% |
+8,280
| New | +$2.65M |
|
|
HSII
1607
DELISTED
Heidrick & Struggles
HSII
| $2.57M | 0.01% |
127,400
+14,900
| +13% | +$275K |
|
|
SNAK
1608
DELISTED
Inventure Foods, Inc.
SNAK
| $2.57M | 0.01% |
193,500
+37,900
| +24% | +$447K |
|
1609
Aviat Networks
AVNW
$253M
| $2.56M | 0.01% |
189,178
-16,867
| -8% | -$222K |
|
|
ADVS
1610
DELISTED
Advent Software Inc
ADVS
| $2.56M | 0.01% |
73,368
+58,268
| +386% | +$1.97M |
|
|
MGI
1611
DELISTED
MoneyGram International, Inc. New
MGI
| $2.56M | 0.01% |
123,087
+67,500
| +121% | +$1.37M |
|
|
EQU
1612
DELISTED
EQUAL ENERGY LTD COM
EQU
| $2.56M | 0.01% |
+478,751
| New | +$2.36M |
|
|
IDXG
1613
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $2.55M | 0.01% |
5,309
+14
| +0.3% | +$6.84K |
|
|
SMT
1614
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
| $2.55M | 0.01% |
116,619
+12,849
| +12% | +$311K |
|
1615
Caterpillar
CAT
$361B
| $2.55M | 0.01% |
+28,100
| New | +$2.4M |
|
|
EFC
1616
Ellington Financial
EFC
$1.69B
| $2.55M | 0.01% |
+112,474
| New | +$2.59M |
|
1617
Willis Lease Finance
WLFC
$1.65B
| $2.55M | 0.01% |
440,400
+148,200
| +51% | +$844K |
|
1618
Mind CTI
MNDO
$21.6M
| $2.55M | 0.01% |
1,266,589
+21,989
| +2% | +$40K |
|
1619
Embotelladora Andina Series A
AKO.A
$3.53B
| $2.54M | 0.01% |
120,900
+1,200
| +1% | +$28.4K |
|
|
ZNH
1620
DELISTED
China Southern Airlines Company Limited
ZNH
| $2.54M | 0.01% |
128,500
-17,300
| -12% | -$338K |
|
|
SP
1621
DELISTED
SP Plus Corporation
SP
| $2.54M | 0.01% |
97,400
+25,700
| +36% | +$663K |
|
1622
Ameris Bancorp
ABCB
$5.89B
| $2.52M | 0.01% |
119,570
+69,770
| +140% | +$1.34M |
|
|
KSPN
1623
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $2.52M | 0.01% |
28,515
-735
| -3% | -$63.8K |
|
1624
Camtek
CAMT
$5.92B
| $2.52M | 0.01% |
621,600
+143,900
| +30% | +$392K |
|
1625
GSI Technology
GSIT
$201M
| $2.52M | 0.01% |
378,700
-13,179
| -3% | -$89K |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.